What is the recommended approach to managing a patient infected with hepatitis C virus who has been on combination interferon and ribavirin therapy and who has developed peripheral neuropathy?

The FDA approval was based on data from two Phase 3 studies, PATH and PRIMA. CSL Behring announced that the Food and Drug Administration (FDA) has approved Privigen (immune globulin intravenous [human ...

In this guide, explore peripheral neuropathy in detail—from its causes and types to key symptoms and more. Learn everything ...

Rockville, MD - The disease-modifying antirheumatic drug leflunomide (Arava, Aventis) is associated with peripheral neuropathy in some patients, say FDA researchers who reviewed 80 case reports ...

PHOENIX -- A subcutaneous infusion of efgartigimod cut the risk of relapse in patients with a rare but serious immune-mediated neuropathy, according to the phase II ADHERE trial. Patients with ...

Discovery of the antigenic targets associated with nerve-specific autoimmune diseases is a crucial step in understanding their pathogenesis The identification of highly disease-specific autoantibodies ...

Dr. Todd Singleton, nationally acclaimed chiropractic physician, introduces an innovative approach to addressing neuropathy, a condition resulting in nerve damage and excruciating pain. This ...

(RTTNews) - argenx SE (ARGX) announced that Japan's Ministry of Health, Labour and Welfare (MHLW) approved VYVDURA for adults with chronic inflammatory demyelinating polyneuropathy. VYVDURA is ...

Neurologic complications of inflammatory bowel disease (IBD) are rare but can have severe consequences if not addressed immediately. The incidence and prevalence depends on which subcategory of ...

Chronic Inflammatory Demyelinating Polyneuropathy Companies such as Takeda, Sanofi, Johnson & Johnson Services, Immunovant, UCB S.A., GeNeuro, Nanjing IASO ...

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare, acquired neurological disorder with heterogeneous presentation. It is a peripheral nerve system immune-mediated condition which ...